Neuropeptide AF induces anxiety-like and antidepressant-like behavior in mice

Miklós Palotai, G. Telegdy, M. Tanaka, Zsolt Bagosi, M. Jászberényi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Little is known about the action of neuropeptide AF (NPAF) on anxiety and depression. Only our previous study provides evidence that NPAF induces anxiety-like behavior in rats. Therefore, the aim of the present study was to investigate the action of NPAF on depression-like behavior and the underlying neurotransmissions in mice. In order to determine whether there are species differences between rats and mice, we have investigated the action of NPAF on anxiety-like behavior in mice as well. A modified forced swimming test (mFST) and an elevated plus maze test (EPMT) were used to investigate the depression and anxiety-related behaviors, respectively. Mice were treated with NPAF 30min prior to the tests. In the mFST, the animals were pretreated with a non-selective muscarinic acetylcholine receptor antagonist, atropine, a non-selective 5-HT2 serotonergic receptor antagonist, cyproheptadine, a mixed 5-HT1/5-HT2 serotonergic receptor antagonist, methysergide, a D2/D3/D4 dopamine receptor antagonist, haloperidol, a α1-adrenergic receptor antagonist, prazosin or a non-selective β-adrenergic receptor antagonist, propranolol 30min before the NPAF administration. In the mFST, NPAF decreased the immobility time and increased the climbing and swimming times. This action was reversed completely by methysergide and partially by atropine, whereas cyproheptadine, haloperidol, prazosin and propranolol were ineffective. In the EPMT, NPAF decreased the time spent in the arms (open/open+closed). Our results demonstrate that NPAF induces anti-depressant-like behavior in mice, which is mediated, at least in part, through 5HT2-serotonergic and muscarinic cholinergic neurotransmissions. In addition, the NPAF-induced anxiety is species-independent, since it develops also in mice.

Original languageEnglish
Pages (from-to)264-269
Number of pages6
JournalBehavioural Brain Research
Volume274
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Antidepressive Agents
Anxiety
Cyproheptadine
Methysergide
Adrenergic Antagonists
Prazosin
Haloperidol
Depression
Atropine
Propranolol
Synaptic Transmission
Cholinergic Agents
A18Famide
Dopamine Antagonists
Cholinergic Antagonists
Muscarinic Receptors

Keywords

  • Elevated plus maze test
  • Forced swimming test
  • Neuropeptide AF
  • Neurotransmitter

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Medicine(all)

Cite this

Neuropeptide AF induces anxiety-like and antidepressant-like behavior in mice. / Palotai, Miklós; Telegdy, G.; Tanaka, M.; Bagosi, Zsolt; Jászberényi, M.

In: Behavioural Brain Research, Vol. 274, 01.11.2014, p. 264-269.

Research output: Contribution to journalArticle

@article{1c01d22d46474fa48dddb4cdc0f01430,
title = "Neuropeptide AF induces anxiety-like and antidepressant-like behavior in mice",
abstract = "Little is known about the action of neuropeptide AF (NPAF) on anxiety and depression. Only our previous study provides evidence that NPAF induces anxiety-like behavior in rats. Therefore, the aim of the present study was to investigate the action of NPAF on depression-like behavior and the underlying neurotransmissions in mice. In order to determine whether there are species differences between rats and mice, we have investigated the action of NPAF on anxiety-like behavior in mice as well. A modified forced swimming test (mFST) and an elevated plus maze test (EPMT) were used to investigate the depression and anxiety-related behaviors, respectively. Mice were treated with NPAF 30min prior to the tests. In the mFST, the animals were pretreated with a non-selective muscarinic acetylcholine receptor antagonist, atropine, a non-selective 5-HT2 serotonergic receptor antagonist, cyproheptadine, a mixed 5-HT1/5-HT2 serotonergic receptor antagonist, methysergide, a D2/D3/D4 dopamine receptor antagonist, haloperidol, a α1/α2β-adrenergic receptor antagonist, prazosin or a non-selective β-adrenergic receptor antagonist, propranolol 30min before the NPAF administration. In the mFST, NPAF decreased the immobility time and increased the climbing and swimming times. This action was reversed completely by methysergide and partially by atropine, whereas cyproheptadine, haloperidol, prazosin and propranolol were ineffective. In the EPMT, NPAF decreased the time spent in the arms (open/open+closed). Our results demonstrate that NPAF induces anti-depressant-like behavior in mice, which is mediated, at least in part, through 5HT2-serotonergic and muscarinic cholinergic neurotransmissions. In addition, the NPAF-induced anxiety is species-independent, since it develops also in mice.",
keywords = "Elevated plus maze test, Forced swimming test, Neuropeptide AF, Neurotransmitter",
author = "Mikl{\'o}s Palotai and G. Telegdy and M. Tanaka and Zsolt Bagosi and M. J{\'a}szber{\'e}nyi",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.bbr.2014.08.007",
language = "English",
volume = "274",
pages = "264--269",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

TY - JOUR

T1 - Neuropeptide AF induces anxiety-like and antidepressant-like behavior in mice

AU - Palotai, Miklós

AU - Telegdy, G.

AU - Tanaka, M.

AU - Bagosi, Zsolt

AU - Jászberényi, M.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Little is known about the action of neuropeptide AF (NPAF) on anxiety and depression. Only our previous study provides evidence that NPAF induces anxiety-like behavior in rats. Therefore, the aim of the present study was to investigate the action of NPAF on depression-like behavior and the underlying neurotransmissions in mice. In order to determine whether there are species differences between rats and mice, we have investigated the action of NPAF on anxiety-like behavior in mice as well. A modified forced swimming test (mFST) and an elevated plus maze test (EPMT) were used to investigate the depression and anxiety-related behaviors, respectively. Mice were treated with NPAF 30min prior to the tests. In the mFST, the animals were pretreated with a non-selective muscarinic acetylcholine receptor antagonist, atropine, a non-selective 5-HT2 serotonergic receptor antagonist, cyproheptadine, a mixed 5-HT1/5-HT2 serotonergic receptor antagonist, methysergide, a D2/D3/D4 dopamine receptor antagonist, haloperidol, a α1/α2β-adrenergic receptor antagonist, prazosin or a non-selective β-adrenergic receptor antagonist, propranolol 30min before the NPAF administration. In the mFST, NPAF decreased the immobility time and increased the climbing and swimming times. This action was reversed completely by methysergide and partially by atropine, whereas cyproheptadine, haloperidol, prazosin and propranolol were ineffective. In the EPMT, NPAF decreased the time spent in the arms (open/open+closed). Our results demonstrate that NPAF induces anti-depressant-like behavior in mice, which is mediated, at least in part, through 5HT2-serotonergic and muscarinic cholinergic neurotransmissions. In addition, the NPAF-induced anxiety is species-independent, since it develops also in mice.

AB - Little is known about the action of neuropeptide AF (NPAF) on anxiety and depression. Only our previous study provides evidence that NPAF induces anxiety-like behavior in rats. Therefore, the aim of the present study was to investigate the action of NPAF on depression-like behavior and the underlying neurotransmissions in mice. In order to determine whether there are species differences between rats and mice, we have investigated the action of NPAF on anxiety-like behavior in mice as well. A modified forced swimming test (mFST) and an elevated plus maze test (EPMT) were used to investigate the depression and anxiety-related behaviors, respectively. Mice were treated with NPAF 30min prior to the tests. In the mFST, the animals were pretreated with a non-selective muscarinic acetylcholine receptor antagonist, atropine, a non-selective 5-HT2 serotonergic receptor antagonist, cyproheptadine, a mixed 5-HT1/5-HT2 serotonergic receptor antagonist, methysergide, a D2/D3/D4 dopamine receptor antagonist, haloperidol, a α1/α2β-adrenergic receptor antagonist, prazosin or a non-selective β-adrenergic receptor antagonist, propranolol 30min before the NPAF administration. In the mFST, NPAF decreased the immobility time and increased the climbing and swimming times. This action was reversed completely by methysergide and partially by atropine, whereas cyproheptadine, haloperidol, prazosin and propranolol were ineffective. In the EPMT, NPAF decreased the time spent in the arms (open/open+closed). Our results demonstrate that NPAF induces anti-depressant-like behavior in mice, which is mediated, at least in part, through 5HT2-serotonergic and muscarinic cholinergic neurotransmissions. In addition, the NPAF-induced anxiety is species-independent, since it develops also in mice.

KW - Elevated plus maze test

KW - Forced swimming test

KW - Neuropeptide AF

KW - Neurotransmitter

UR - http://www.scopus.com/inward/record.url?scp=84906772825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906772825&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2014.08.007

DO - 10.1016/j.bbr.2014.08.007

M3 - Article

VL - 274

SP - 264

EP - 269

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -